Pathological complete response following immunotherapy in dMMR/MSI-H ascending colon primary squamous cell carcinoma: a case report

Read full text Summarise with VIRAT
Authors: Chaoxian Xiong, Wei Wang, Xuefeng Cha, Jie Li, Y. He, Xiaoxia Li, Shulian Tang, Quan Yang, Kun Yu
Cited by: 0
References: 44

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Primary colon squamous cell carcinoma (SCC) is an extremely rare malignancy and associated with a poor prognosis. This case report describes a patient with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) ascending colon SCC, who was treated at our institution. After receiving four cycles of programmed cell death -1 (PD-1) blockade monotherapy, the tumor exhibited significant regression, and pathological complete response (pCR) was achieved following surgical resection. This case demonstrates that Anti-PD-1 therapy can induce clinically meaningful tumor regression even in this rare colon SCC subtype, suggesting a potential treatment strategy for dMMR/MSI-H colon SCC. These findings may provide valuable insights for clinicians managing similar cases. However, the feasibility and safety of immunotherapy in dMMR/MSI-H primary colon SCC require further validation through additional clinical studies.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Genetic factors in colorectal cancer Colorectal and Anal Carcinomas

Publication details

Journal / source
Frontiers in Immunology
Volume
17
Pages
1688501–1688501
Publication date
25 March 2026
Language
EN